{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:02:37Z","timestamp":1790373757079,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant inherited condition affecting multiple endocrine organs, resulting in significant morbidity and decreased life expectancy. Early tumor identification allows for timely patient management, reduces morbidity, and improves disease outcomes. Patients with MEN1 typically present with primary hyperparathyroidism caused by multiple parathyroid tumors, however, thymic and bronchial carcinoid tumors are also less common manifestations. MEN1-related neuroendocrine tumors often show hematogenous metastasis, with the liver being the most common metastatic site. Skeletal metastases from neuroendocrine tumors are extremely rare.<\/jats:p>\n                <jats:p>As few as 50 case reports were identified in a recently published literature review on skeletal metastases from carcinoid tumors. To our knowledge, studies related to MEN1 have not been previously conducted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present a case of MEN1-related atypical ovarian carcinoid presenting as the first disease manifestation in a 30-year old woman. After two years, another atypical carcinoid was incidentally diagnosed in the contralateral ovary during a caesarean section. Syndromic MEN1 was not diagnosed clinically despite her young age and bilateral involvement. The patient remained disease-free for two years without further adjuvant treatment prior to clinic presentation with complaints of chest discomfort and body pain. Radiologic and pathologic investigations identified multifocal simultaneous neuroendocrine tumors involving the parathyroid, thymus, pancreas, and adrenal glands, in addition to multiple other metastatic sites. The findings ultimately resulted in the patient being diagnosed with MEN1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This extremely rare case emphasizes that ovarian carcinoids, especially when bilateral, could be the initial manifestation of MEN1. The significance of this differential diagnosis was highlighted by the subsequent detection of widespread skeletal metastasis resulting from the carcinoid tumors. A low threshold of suspicion, systemic diagnostic work-up, and regular follow-up are of utmost importance to timely diagnosis of MEN1.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-019-6332-7","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T14:03:10Z","timestamp":1573740190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Atypical ovarian carcinoid tumor with widespread skeletal metastases: a case report of multiple endocrine neoplasia type 1 in a young woman"],"prefix":"10.1186","volume":"19","author":[{"given":"Lei","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huina","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0737-3646","authenticated-orcid":false,"given":"Yuehong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"issue":"5311","key":"6332_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.276.5311.404","volume":"276","author":"SC Chandrasekharappa","year":"1997","unstructured":"Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276(5311):404\u20137.","journal-title":"Science"},{"issue":"1","key":"6332_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2265.2009.03662.x","volume":"72","author":"J Burgess","year":"2010","unstructured":"Burgess J. How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol. 2010;72(1):13\u20136.","journal-title":"Clin Endocrinol"},{"issue":"12","key":"6332_CR3","first-page":"4776","volume":"85","author":"CA Stratakis","year":"2000","unstructured":"Stratakis CA, Schussheim DH, Freedman SM, Keil MF, Pack SD, Agarwal SK, Skarulis MC, Weil RJ, Lubensky IA, Zhuang Z, et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2000;85(12):4776\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6332_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","volume":"58","author":"F Giusti","year":"2017","unstructured":"Giusti F, Cianferotti L, Boaretto F, Cetani F, Cioppi F, Colao A, Davi MV, Faggiano A, Fanciulli G, Ferolla P, et al. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database. Endocrine. 2017;58(2):349\u201359.","journal-title":"Endocrine"},{"issue":"9","key":"6332_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","volume":"89","author":"D Trump","year":"1996","unstructured":"Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM : monthly journal of the Association of Physicians. 1996;89(9):653\u201369.","journal-title":"QJM : monthly journal of the Association of Physicians"},{"issue":"1","key":"6332_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1530\/EJE-10-0950","volume":"165","author":"P Goudet","year":"2011","unstructured":"Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Menegaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P, et al. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs endocrines. Eur J Endocrinol. 2011;165(1):97\u2013105.","journal-title":"Eur J Endocrinol"},{"key":"6332_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-1172-1-38","volume":"1","author":"F Marini","year":"2006","unstructured":"Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, Brandi ML. Multiple endocrine neoplasia type 1. Orphanet journal of rare diseases. 2006;1:38.","journal-title":"Orphanet journal of rare diseases"},{"issue":"9","key":"6332_CR8","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990\u20133011.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6332_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","volume":"14","author":"JM de Laat","year":"2016","unstructured":"de Laat JM, van der Luijt RB, Pieterman CR, Oostveen MP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, et al. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med. 2016;14(1):182.","journal-title":"BMC Med"},{"key":"6332_CR10","doi-asserted-by":"crossref","unstructured":"Ramundo V, Milone F, Severino R, Savastano S, Di Somma C, Vuolo L, De Luca L, Lombardi G, Colao A, Faggiano A: Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2011, 43(11):794\u2013800.","DOI":"10.1055\/s-0031-1286324"},{"issue":"3","key":"6332_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/jc.2015-3766","volume":"101","author":"RS van Leeuwaarde","year":"2016","unstructured":"van Leeuwaarde RS, van Nesselrooij BP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, et al. Impact of delay in diagnosis in outcomes in MEN1: results from the Dutch MEN1 study group. J Clin Endocrinol Metab. 2016;101(3):1159\u201365.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6332_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1210\/jc.2002-021314","volume":"88","author":"F Gibril","year":"2003","unstructured":"Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Louie A, Entsuah LK, Huang K, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003;88(3):1066\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6332_CR13","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1210\/jc.2004-1155","volume":"90","author":"P Ferolla","year":"2005","unstructured":"Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano G, Avenia N, Daddi G, Puma F, Ribacchi R, Santeusanio F, et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab. 2005;90(5):2603\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"6332_CR14","doi-asserted-by":"crossref","unstructured":"Singh Ospina N, Thompson GB, C. Nichols F r, Cassivi SD, Young WF, Jr.: Thymic and bronchial carcinoid tumors in multiple endocrine Neoplasia type 1: the Mayo Clinic experience from 1977 to 2013. Hormones & cancer 2015, 6(5\u20136):247\u2013253.","DOI":"10.1007\/s12672-015-0228-z"},{"issue":"8","key":"6332_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1210\/js.2018-00178","volume":"2","author":"F Raue","year":"2018","unstructured":"Raue F, Frank-Raue K. Update on multiple endocrine Neoplasia type 2: focus on medullary thyroid carcinoma. Journal of the Endocrine Society. 2018;2(8):933\u201343.","journal-title":"Journal of the Endocrine Society"},{"issue":"2","key":"6332_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","volume":"34","author":"P Goudet","year":"2010","unstructured":"Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, Niccoli P, Menegaux F, Chabrier G, Borson-Chazot F, et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs endocrines) cohort study among 758 patients. World J Surg. 2010;34(2):249\u201355.","journal-title":"World J Surg"},{"key":"6332_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fendo.2018.00533","volume":"9","author":"JM de Laat","year":"2018","unstructured":"de Laat JM, van Leeuwaarde RS, Valk GD. The importance of an early and accurate MEN1 diagnosis. Front Endocrinol. 2018;9:533.","journal-title":"Front Endocrinol"},{"issue":"6","key":"6332_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s002689900438","volume":"22","author":"GM Doherty","year":"1998","unstructured":"Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr, Norton JA. Lethality of multiple endocrine neoplasia type I. World J Surg. 1998;22(6):581\u20136 discussion 586-587.","journal-title":"World J Surg"},{"issue":"3","key":"6332_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","volume":"92","author":"T Ito","year":"2013","unstructured":"Ito T, Igarashi H, Uehara H, Berna MJ, Jensen RT. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine. 2013;92(3):135\u201381.","journal-title":"Medicine"},{"issue":"5","key":"6332_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.clineuro.2010.01.008","volume":"112","author":"PM Arnold","year":"2010","unstructured":"Arnold PM, Floyd HE, Anderson KK, Newell KL. Surgical management of carcinoid tumors metastatic to the spine: report of three cases. Clin Neurol Neurosurg. 2010;112(5):443\u20135.","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"6332_CR21","first-page":"283","volume":"4","author":"DB Kirkpatrick","year":"1975","unstructured":"Kirkpatrick DB, Dawson E, Haskell CM, Batzdorf U. Metastatic carcinoid presenting as a spinal tumor. Surg Neurol. 1975;4(3):283\u20137.","journal-title":"Surg Neurol"},{"issue":"2","key":"6332_CR22","first-page":"184","volume":"44","author":"WG Meijer","year":"2003","unstructured":"Meijer WG, van der Veer E, Jager PL, van der Jagt EJ, Piers BA, Kema IP, de Vries EG, Willemse PH. Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2003;44(2):184\u201391.","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"issue":"3","key":"6332_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0002-9343(85)90313-4","volume":"79","author":"EM Ross","year":"1985","unstructured":"Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med. 1985;79(3):339\u201354.","journal-title":"Am J Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6332-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:08:22Z","timestamp":1605226102000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6332-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6332"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6332-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]},"assertion":[{"value":"25 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of The Second Hospital of Hebei Medical University, Shijiazhuang, China.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided written informed consent for the publication of her data and associated images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1107"}}